Sunday 22 Dec, 2024 08:38 AM
Site map | Locate Us | Login
   Can Fin Homes CFO Apurav Agarwal resigns    Auro Pharma gets UK MHRA nod for cancer drug    Reliance Inds arm to acquire 45% stake in Health Alliance Group    Mazagon Dock Shipbuilders delivers two warships to Indian Navy    Dalmia Bharat's president Rajiv Bansal resigns    Cupid bags order worth Rs 18-cr from UNFPA    NTPC Green inks MoU with Govt of Bihar    IDBI Bank board to mull fund-raising proposal on Dec 31    NRB Industrial Bearings CFO Gulestan Kolah resigns    Shilpa Medicare gets GMP certification for Hyderabad Facility    Siemens Ltd leads losers in 'A' group    Restaurant Brands Asia to raise Rs 500 crore via QIP    NBCC bags orders worth Rs 298 cr for healthcare infrastructure projects    Tantia Constructions Ltd leads losers in 'B' group    Volumes soar at Aegis Logistics Ltd counter 
Saravan Stocks
       
Company Background
Dr Reddys Laboratories Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value(R) NSE Symbol Div & Yield % Market Cap (Rs.Cr) P/E(TTM) EPS(TTM) Face Value(R)
500124 INE089A01031 322.4783105 DRREDDY 0.6 112015.49 23.29 57.64 1
Incorporation Year 1984  
Registered Office 8-2-337 Road No 3,Banjara Hills,
Hyderabad,
Telangana-500034
Telephone 91-40-49002900  
Fax 91-40-49002999  
Chairman K Satish Reddy  
Managing Director G V Prasad  
Company Secretary K Randhir Singh  
Auditor S R Batliboi & Associates LLP  
Face Value 1  
Market Lot 1  
Listing BSE,MSEI ,New York,NSE  
Registrar Big Share Services Pvt Ltd
3rd Flr 306 Rightwin,Amrutha Ville,Somajiguda,Hyderabad-500082
 
   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 37678800
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd